PeptideDB

DN401 2135749-60-7

DN401 2135749-60-7

CAS No.: 2135749-60-7

DN401 is a potent TRAP1 inhibitor with IC50 of 79 nM. DN401 has a weak inhibitory effect on Hsp90 (IC50 of 698 nM). DN40
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

DN401 is a potent TRAP1 inhibitor with IC50 of 79 nM. DN401 has a weak inhibitory effect on Hsp90 (IC50 of 698 nM). DN401 inactivates mitochondrial TRAP1 and has potent anticancer activity.

Physicochemical Properties


Molecular Formula C13H9BRCLN5O2
Molecular Weight 382.60
CAS # 2135749-60-7
Appearance Off-white to light yellow solid powder
SMILES

BrC1C=C2C(=CC=1CN1C3C(=C(N=C(N)N=3)Cl)C=N1)OCO2

Synonyms

Panvotinib-401; Pan-401
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets TRAP1 79 nM (IC50); HSP90 698 nM (IC50)
ln Vitro DN401 (5-20 µM; 24 hours) has excellent cancer-specific cytotoxicity, but has reduced cytotoxicity in normal cells[1]. DN401 (20 µM; 6 hours) inhibits the expression of Chk1 and Akt in HeLa cells[1].
ln Vivo DN401 (30 mg/kg; intraperitoneal injection; once a day; for 14 days) reduced tumor growth and increased apoptosis in tumor tissues without causing weight loss or histological abnormalities [1].
Cell Assay Cell Viability Assay[1]
Cell Types: HeLa, SK-HEP-1, T98G, H460, and PC3 cells Tested
Tested Concentrations: 5 µM, 10 µM, 15 µM, 20 µM
Incubation Duration: 24 hours
Experimental Results: Exhibited cytotoxic activity.

Western Blot Analysis[1]
Cell Types: HeLa cells Tested
Tested Concentrations: 20 µM
Incubation Duration: 6 hours
Experimental Results: Inhibited the expression of Chk1 and Akt.
Animal Protocol Animal/Disease Models: 6-week-old BALB/c nu/nu male mice injected with PC3 cells[1]
Doses: 30 mg/kg
Route of Administration: ip; once daily; for 14 days
Experimental Results: Reduced tumor growth.
References

[1]. Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors. J Med Chem. 2017 Sep 14;60(17):7569-7578.


Solubility Data


Solubility (In Vitro) DMSO : ~17.5 mg/mL (~45.74 mM; with ultrasonication (<60°C))
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6137 mL 13.0685 mL 26.1370 mL
5 mM 0.5227 mL 2.6137 mL 5.2274 mL
10 mM 0.2614 mL 1.3068 mL 2.6137 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.